# PhoreMost

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phoremost

- Industry: Pharmaceuticals
- Headquarters: Cambridge, UK
- Website: www.phoremost.com/
- Total disclosed funding: $78M
- Latest round: Series B (Aug 27, 2024)
- Investors on record: 10

## About

Founded in 2014 and based in Cambridge, UK, PhoreMost Ltd is a biotechnology company that provides drug discovery and other pharmaceutical products and processes for cancer and other diseases. In August 2024, PhoreMost Ltd raised GBP 9.15 million in Series B funding led by Parkwalk Advisors, with participation from Amadeus Capital Partners, Astellas Venture Management, and the Business Growth Fund.

PhoreMost is a drug discovery company focused on identifying and developing therapies for difficult-to-target diseases. Utilizing its proprietary SITESEEKER® technology, the firm employs PROTEINi® libraries to discover novel drug targets and develop strategies for targeting them. The company is advancing a pipeline that includes programs in oncology and targeted protein degradation (TPD). 

The company intends to use the August 2024 funding to progress the pipeline of its novel degrader programs in oncology and inflammatory diseases and support the further deployment of the GlueSEEKER™ platform.

## Funding rounds

- Series B, Aug 27, 2024, $12M — Amadeus Capital Partners, Astellas Venture Management, BGF Investment Management, Parkwalk Advisors
- Series B, Mar 17, 2021, $42M — Astellas Venture Management, BGF Investment Management, Parkwalk Advisors, O2h Ventures, Trend Investment Group, XtalPi Inc., Morningside
- Series A, May 1, 2018, $15M — Amadeus Capital Partners, Cambridge Enterprise, 5Y Capital, Parkwalk Advisors
- Series A, Apr 7, 2015, $5.9M — Amadeus Capital Partners, Cambridge Enterprise
- Seed, Mar 11, 2015, $3.8M — Amadeus Capital Partners, Parkwalk Advisors

## Investors

- Amadeus Capital Partners (https://capitalatlas.ai/funds/amadeus-capital-partners) — Seed, Series A, Series B
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Seed, Series A, Series B
- Cambridge Enterprise — Series A
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A
- Astellas Venture Management (https://capitalatlas.ai/funds/astellas-venture-management) — Series B
- BGF Investment Management (https://capitalatlas.ai/funds/bgf-investment-management) — Series B
- O2h Ventures (https://capitalatlas.ai/funds/o2h-ventures) — Series B
- Trend Investment Group (https://capitalatlas.ai/funds/trend-investment-group) — Series B
- XtalPi Inc. — Series B
- Morningside (https://capitalatlas.ai/funds/morningside) — Series B